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Summary
Background: Disruption of circadian (daily) timekeeping
enhances the risk of metabolic syndrome, obesity, and type
2 diabetes. While clinical observations have suggested that
insulin action is not constant throughout the 24 hr cycle, its
magnitude and periodicity have not been assessed. Moreover,
when circadian rhythmicity is absent or severely disrupted, it is
not knownwhether insulin action will lock to the peak, nadir, or
mean of the normal periodicity of insulin action.
Results: We used hyperinsulinemic-euglycemic clamps to
show a bona fide circadian rhythm of insulin action; mice are
most resistant to insulin during their daily phase of relative
inactivity. Moreover, clock-disrupted Bmal1-knockout mice
are locked into the trough of insulin action and lack rhythmicity
in insulin action and activity patterns. When rhythmicity is
rescued in the Bmal1-knockout mice by expression of the
paralogous gene Bmal2, insulin action and activity patterns
are restored. When challenged with a high-fat diet, arhythmic
mice (either Bmal1-knockout mice or wild-type mice made
arhythmic by exposure to constant light) were obese prone.
Adipose tissue explants obtained from high-fat-fed mice
have their own periodicity that was longer than animals on
a chow diet.
Conclusions: This study provides rigorous documentation for
a circadian rhythm of insulin action and demonstrates that
disturbing the natural rhythmicity of insulin action will disrupt
the rhythmic internal environment of insulin sensitive tissue,
thereby predisposing the animals to insulin resistance and
obesity.
Introduction
Many physiological processes display day-night rhythms,
including feeding behavior, lipid/carbohydrate metabolism,
and sleep. These daily oscillations are controlled by the circa-
dian biological clock [1]. Circadian desynchrony in humans,
a characteristic of shift work, jet lag, and/or sleep disruption,
can have profound effects on both normal body weight regula-
tion and glucose/lipid homeostasis [2–4]. Improper circadian
entrainment is associated with the onset of metabolic
syndrome, obesity, and type 2 diabetes. Disruption of circa-
dian rhythmicity may interact with other susceptibility factors
to precipitate the disease state [2, 5, 6]. Many hormones that
modulate insulin secretion, glucose homeostasis, and feeding
are regulated cyclically by the circadian system, including
orexin, leptin, glucagon, cortisol, growth hormone, catechol-
amines, and melatonin [6, 7]. Another linkage between clock-*Correspondence: carl.h.johnson@vanderbilt.eduregulated sleep and insulin resistance/type 2 diabetes is the
association between short sleep duration (due to e.g.,
insomnia and/or circadian disruption) and the risk of obesity
and diabetes [8, 9].
In any given tissue, 3%–10% of messenger RNA transcripts
show circadian rhythmicity in vivo [10, 11], including those
encoding transcriptional factors such as DBP, Rev-erba,
PPARg, HLF, and TEF [6, 12, 13]. These transcriptional factors
then regulate downstream target genes involved in different
biochemical pathways, including those relating to metabolism
of glucose and lipids; synthesis of cholesterol, fatty acids,
and bile acids; and mitochondrial oxidative phosphorylation
[11, 14, 15]. Therefore, polymorphisms of core clock genes
or of clock-controlled hormone receptor genes that might
influence the regulation of these metabolic pathways could
have health consequences in humans. Indeed, polymorphisms
of the clock genes Bmal1 (aka Arntl1 in humans) and Clock
are associated with obesity, type 2 diabetes, and hypertension
[16, 17]. Moreover, genome-wide association studies show an
increased risk of type 2 diabetes associated with variants of
the gene (mtnr1b) encoding a receptor for the clock-controlled
hormone melatonin [18, 19].
Disruptions of the normal light/dark cycle in wild-type
mice—analogous to shiftwork disruption in humans—can
lead to increased body weight, hyperleptinemia, and elevated
insulin secretion [20, 21]. Altering the circadian timing of food
intake stimulates weight gain in mice [22]. Conversely, feeding
a high-fat diet (HFD) can itself change the period of the circa-
dian activity rhythm and alter the expression of core clock
genes in mice in vivo [23]. Genetic mouse models have also
elucidated the linkage between metabolism and the circadian
system. For example, mice that are homozygous for a loss-of-
functionmutation in the circadian geneClock overeat, become
obese and develop hyperglycemia and dyslipidemia [24].
These Clock mutant mice develop the adipocyte hypertrophy
and excessive accumulation of fat in the liver that are hall-
marks of the metabolic syndrome. Regulation of the histone
deacetylase Hdac3 by the clock-regulated transcriptional
factor Rev-erba directs a circadian rhythm of histone acetyla-
tion and gene expression that is required for normal hepatic
lipid metabolism [25, 26]. Knockout of the three circadian
Period genes in mice cause arhythmicity in behavior and
increased weight gain on high-fat diets [27]. Similarly, Bmal1-
knockout mice display arhythmic behavior in constant condi-
tions, increased fat deposition, elevated triglycerides/free fatty
acid levels, and disrupted insulin responsiveness [28–32].
Therefore, a preponderance of evidence supports a close
relationship between clocks and metabolism. Consequently,
manipulation of biological timing could be used to develop
noninvasive therapies for metabolic disorders. However,
whether insulin action itself is rhythmic is unclear, nor has
the impact of clock disruption upon insulin action been well
characterized. Using a hyperinsulinemic-euglycemic clamp
procedure that was developed at Vanderbilt to eliminate the
need to handle, restrain, or stress mice [33, 34], we show
herein that mice show a bona fide circadian rhythm of insulin
action such that mice are most resistant to insulin during the
phase of relative inactivity. Knockout of the Bmal1 gene leads
Figure 1. Hyperinsulinemic-Euglycemic Clamps
on Conscious, Unrestrained Wild-Type and
Bmal1-Knockout Mice at Four Circadian Phases
under Constant Red Light
(A and B) Arterial glucose levels (left panels) and
glucose infusion rates (GIR, right panels) during
hyperinsulinemic-euglycemic clamps for wild-
type (A) and B1ko (B) mice are shown for four
time points under constant red light (CT0 =
subjective dawn; CT12 = subjective dusk). The
light/dark and fasting protocol prior to the clamps
is shown in Figure S1.
(C) Left: Arterial glucose levels in mice subjected
to a 5 hr fast (the average of 210 and 0 min prior
to the start of clamps, left) during clamps for WT
and B1ko mice (left panel; open rectangle, WT;
solid rectangle, B1ko) at four time points. Right:
Glucose infusion rates for the final 50 min (steady
state of glucose levels) during the clamps at
four circadian time points under constant red
light (right panel; open rectangle, WT; solid rect-
angle, B1ko). The times or phases of the clamp
measurements are plotted as both hours in red
light and circadian time (CT; clamp time should
not be expressed in CT for B1ko mice since the
clock appears to be abolished in these animals).
Data are presented as mean 6 SEM (WT, six to
eight mice/group; B1ko, three to five mice/
group). Asterisks denote the phase of the WT
data (CT7) that is significantly different (p <
0.05) from the other phases of the WT samples
for both fasting glucose levels and GIRs as
described in the text.
See also Figure S1.
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373to profound insulin resistance, which can be rescued by con-
stitutive expression of the Bmal2 gene. In addition to insulin
resistance and hyperglycemia, arhythmic mice exhibit meta-
bolic phenotypes related to fat accumulation. By analysis of
food intake and activity levels in rhythmic versus arhythmic
mice in light/dark and continuous light, these metabolic
phenotypes are associated with disruption of rhythmic circa-
dian behavior.
Results
Circadian Rhythm of Insulin Action and Its Elimination
in ‘‘Clockless’’ Mice
The hyperinsulinemic-euglycemic clamp, or insulin clamp, is
widely considered to be the ‘‘gold standard’’ method for as-
sessing insulin action in vivo. During an insulin clamp, hyperin-
sulinemia is achieved by constant insulin infusion. Euglycemia
is maintained via a concomitant glucose infusion at a variable
rate. The glucose infusion rate (GIR) is determined by mea-
surement of blood glucose at brief intervals throughout
the experiment and adjustment of the GIR accordingly to
maintain constant blood glucose levels. We applied the insulin
clamp methodology [33, 34] over the circadian cycle in
conscious and unrestrained mice to assess most precisely
circadian control over insulin action and glucose homeostasis
in wild-type mice (WT C57/BL6) and in mice whose key
circadian clock gene Bmal1 has been knocked out (B1ko)
such that the circadian system is abolished or at least severely
disrupted [35].
Our protocol measures GIR during a hyperinsulinemic-
euglycemic clamp at different phases of the circadian cyclein freely roaming, nonstressed mice whose circadian system
is ‘‘free-running’’ in constant dim red light (Figure S1 available
online). This protocol revealed a clear circadian rhythm of
insulin action in WT mice (Figure 1). In particular, mice are
significantly more insulin resistant at hour 19 in constant dim
red light as indicated by a lower GIR (Figures 1A and 1C).
This phase corresponds with the middle of their subjective
day (circadian time 7 [CT7]; see Figure S1), when they are rela-
tively inactive. Constant dim red light is perceived as darkness
by the circadian system of mice [30, 36], so mice in constant
dim red light express their endogenous ‘‘free-running’’ circa-
dian patterns. Statistical analyses of the data depicted in
Figure 1 addressed two questions for both the fasting glucose
levels and GIR data sets: (1) are there significant differences
among the phases of the WT or B1ko samples, and (2) are
the WT and B1ko groups different statistically? One-way
ANOVA analysis of the phase data revealed statistically sig-
nificant phase differences among the WT data for both fasting
glucose levels (peak at CT7, p = 0.004) and for GIR (trough at
CT7, p = 0.047). Therefore, there are circadian differences in
fasting glucose levels and insulin action in WT mice such
that CT7 is the phase that is different for both rhythms; arterial
glucose was higher at the same phase (CT7) when the mice
were less sensitive to insulin as measured with the hyperinsu-
linemic-euglycemic clamp (Figures 1A and 1C) [37].
In contrast, in the B1ko mice, one-way ANOVA analyses
indicate no significant differences in the phase for either
fasting glucose levels (p = 0.163) or GIR (p = 0.675), consistent
with the interpretation of the B1ko strain as being ‘‘clockless.’’
Moreover, one-way ANOVA analyses indicate no significant
differences between the CT7 values of WT with any of the
Figure 2. Hyperinsulinemic-Euglycemic Clamps
on Mice at 25 hr in Dim Red Light
The 25 hr time point is CT13 for WT, B2Tg, and
B1ko/B2Tg mice.
(A and B) Arterial glucose levels (A) and
glucose infusion rates (B) during insulin clamps
for wild-type (WT), Bmal2 transgenic (B2Tg),
Bmal1-knockout (B1ko), and Bmal1ko/Bmal2Tg
(B1koB2Tg) mice.
(C) Arterial glucose levels for mice subjected to
a 5 hr fast (average of times 210 min and 0 min
prior to the initiation of insulin infusion).
(D) Glucose infusion rates during the last 50 min
of the clamps.
(E and F) Arterial insulin (E) and corticosterone (F)
levels during the clamps (open bars, basal; solid
bars, clamp period).
Data are shown as mean 6 SEM (four to seven
mice per group), *p < 0.05, **p < 0.01, ***p <
0.001 compared with WT mice (C and D, one-
way ANOVA with least significant difference
[LSD]), compared with basal levels (E and F,
two-tailed unpaired t test). #p < 0.05 compared
among four genotypes (one-way ANOVA). Insulin
(p<0.001) but not corticosterone (p= 0.557) levels
between the basal and clamp conditions were
significantly different among the four genotypes
as analyzed by two-way ANOVA. Statistically
significant differences among the four genotypes
were revealed by one-way ANOVA for both clamp
insulin levels (p = 0.011, high in B1ko) and clamp
corticosterone levels (p = 0.016, lower in B1ko).
Two-way ANOVA analyses of strain X phase
interaction indicated a significant difference for
insulin levels (p=0.013), but not for corticosterone
levels (p = 0.674). See also Figure S1.
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374values of the B1ko mice for GIR (p = 0.331) or fasting glucose
levels (p = 0.116) (Figure 1C). This means that the disruption of
the circadian system in B1ko mice renders them relatively
insensitive to insulin and locks them into a circadian phase
of insulin action and glucose metabolism that is similar to
that of WT mice in the inactive segment of their daily cycle
(CT7). WT and B1ko mice are significantly different from
each other; two-way ANOVA analyses of the WT and B1ko
data together confirm that the data for these two strains are
significantly different for both the fasting glucose levels (p <
0.0001) and for GIRs (p < 0.0001). Two-way ANOVA analysis
of strain X phase interaction indicated significant difference
for the fasting glucose data (p = 0.001), but not for the GIRs
(p = 0.182).
Expression of Bmal2 Rescues the Insulin Resistance
and Signaling Deficits of B1ko
The circadian clock mechanism in mammals is composed of
autoregulatory transcription and translation feedback loops
of central clock gene expression. These central clock genes
include the positive transcriptional factors BMAL1/BMAL2
and CLOCK/NPAS2 and the feedback repressors PER1/2/3
and CRY1/2 [38–41]. BMAL1 or BMAL2 form heterodimers
with CLOCK or NPAS2 and bind to E-boxes in the promoters
of a large number of target genes [30, 42, 43], including their
own negative regulators Period (Per1, Per2, and Per3) and
Cryptochrome (Cry1 and Cry2). Knockout of the gene encod-
ing BMAL1 (B1ko strain) abolishes the circadian feedback
loop as well as the rhythms of gene expression [35]. In a
previous study, we reported that expression of Bmal2 from
a constitutively expressed promoter (hEF1a promoter) rescuesthe clock phenotypes of B1ko mice, including rhythmic loco-
motor activity and rhythmic oxygen consumption [30]. We
concluded from those data and the original Bmal1-knockout
report [35] that Bmal1 and Bmal2 form a circadian paralogous
pair that is functionally redundant but that in the mouse Bmal2
is regulated by Bmal1 such that knockout of Bmal1 alone
results in a functional knockdown of Bmal2.
We find that transgenic expression of Bmal2 (the B2Tg
mouse) not only restores rhythmicity, but also rescues the
metabolic phenotypes of B1ko that are depicted in Figure 1.
Specifically, the insulin resistance and high fasting arterial
glucose levels are both restored to wild-type levels in the
B1ko mouse when Bmal2 is expressed from a constitutively
expressed promoter (the B1ko/B2Tg mouse), as shown in
Figure 2. This rescue is also obvious from the arterial insulin
levels during the clamp; the high insulin levels and low glucose
infusion rate exhibited by the B1ko mice at the end of the
clamp are eliminated in the B1ko/B2Tg mice (Figure 2E). It is
not clear why basal insulin levels are not high in B1ko mice
(Figure 2E), given their resistance to insulin action (Figures
2B and 2D). A likely explanation is that beta cell function is
compromised in B1ko mice, resulting in inappropriately low
insulin concentrations for the prevailing arterial glucose, as
has been shown to be true by Marcheva et al. [44]. Moreover,
theGIRs forWT versus B2Tg are not significantly different (Fig-
ure 2D), but they are different for fasting glucose (Figure 2C).
Because there were differences for fasting glucose but not
for GIR, these data suggest that expression of Bmal2 may
have some effects on glucose/insulin relationships that are
not restricted to insulin action. Nevertheless, the notable result
is that transgenic expression of Bmal2 overcame the elevated
Figure 3. Regulation of AKT Pathway Signaling
by Bmal1/2
(A) Immunoblots from liver extracts for phospho-
AKT (p-AKT S473 and T308), AKT (total), BMAL1,
cMYC-BMAL2 (cMYC-tagged BMAL2 is the
version of BMAL2 expressed in the B2Tg and
B1ko/B2Tg mice [16]), and b-ACTIN of mice after
hyperinsulinemic-euglycemic clamps. Each lane
comes from a separate mouse (n = 5 for WT, n =
4 for the other groups). The lane between the
B2Tg and the B1ko samples in the BMAL1 and
cMYC-BMAL2 blots shows a molecular weight
standard indicating 75 kD.
(B) Densitometric analyses of the data shown in
(A) for liver extracts. Expression of AKT-pS473
and AKT-pT308 were normalized to total AKT.
(C) Densitometric analyses of the data for muscle
extracts analyzed and plotted as in (B) (see Fig-
ure S2 for the raw immunoblot data).
(B and C) The value of WT was set as 1.0, and
values are expressed as mean 6 SEM of inte-
grated intensity.
(D) Expression of cMYC-BMAL2 in various
tissues of B1ko/B2Tg mice. Results from two
representative mice are shown for liver, muscle,
white adipose tissue (WAT), and brain tissue.
The blot for cMYC-BMAL2 (upper blot) is com-
pared with a blot for a control protein (GAPDH,
lower blot).
In all panels, *p < 0.05, **p < 0.01 compared with
WT or as indicated. See also Figure S2.
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strain. The results shown in Figure 2 are not due to a non-
specific stress to the mutant strains. Our clamp procedure
differs from other clamp procedures that involve restraint
and handling, and it has been demonstrated to be stress free
[33]. In this regard, it is notable that serum corticosterone
levels (an indicator of stress) are low in the threemutant strains
(Figure 2F).
Insulin resistance is associated with the activity of the
serine/threonine protein kinase Akt pathway through the
PI3K/PIP3/Akt signaling cascades, and Akt and TOR signaling
are also important for circadian timing [45]. The reduced GIR
of the B1ko strain is correlated with attenuated activity of the
Akt pathway in response to insulin action, as shown by the
significantly decreased Akt phosphorylation at S473 and
T308 residues in liver and muscle extracts of B1ko mice
(Figure 3). Constitutive expression of Bmal2 can reverse the
attenuation of Akt phosphorylation in the liver, particularly on
the S473 residue (Figure 3B), which would be predicted to
reactivate the Akt pathway. There does not appear to be
a significant rescue of Akt phosphorylation in muscle extracts
of theB1ko/B2Tgmice (Figures 3C andS2). This observation is
consistent with the fact that expression of BMAL2 in the B1ko/
B2Tg mouse is significant in liver, brain, and white adipose
tissue (WAT), but not in muscle (Figure 3D). Moreover, the
low dose of insulin used during the clamp allowed us to detect
any modulation of the impact of insulin on adipose tissue andliver, which are more sensitive to insulin
than ismuscle. It is possible that a higher
dose of insulin would have allowed us to
detect reversal of insulin signaling
defects in muscle of B1ko/B2Tg mice.
Therefore, there is a correlation between
the rescue of circadian rhythmicity byBmal2 expression in the B1ko mouse and the restoration of
wild-type metabolic function.
Clock-Disrupted Mice Are Obesity Prone
In addition to insulin resistance and elevated fasting arterial
glucose (Figures 1 and 2), B1ko mice exhibit abnormal meta-
bolic phenotypes related to fat accumulation. Young mice of
the four genotypes placed on a HFD do not show significant
differences in total body weight after 2 months, but there are
significant differences of body composition in the B1ko strain
(Figures 4A–4C). Specifically, the B1ko mice have a signifi-
cantly elevated percentage of body fat (Figure 4A) with no
significant difference in leanmass (Figures 4B and 4C). Consti-
tutive expression of the Bmal2 gene rescued the B1ko pheno-
type nearly to WT levels (Figures 4A–4C). Food intake was
essentially the same among these four genotypes (Figure 4E),
but B1ko mice had significantly lower and B2Tg mice had
significantly higher levels of activity as compared with WT
and B1ko/B2Tg mice (Figure 4D). The restoration of B1ko
phenotypes to WT levels in the B1ko/B2Tg strain appears to
be correlated with the rescue of rhythmicity and not to some
other effect of Bmal2 expression, as can be observed in the
B1ko/B2Tg mice. We have previously reported that the rescue
of wheel-running rhythmicity in B1ko/B2Tg mice fed with
regular chow is complete for some mice, but not for others
[30]. We continue to observe this phenomenon of rhythmicity
differences with HFD-fed mice whose activity is monitored
Figure 4. Body Composition, Food Consumption, and Locomotor Activity in Four Different Strains of Mice Fed a High-Fat Diet
Mice were fed HFD starting at an age of 1 month and maintained under LD 12:12 (12 hr light:12 hr dark, lights on 6:00 a.m.–6:00 p.m.).
(A and B) Fat mass of these mice at age 3 months (2 months on HFD) (A) and lean mass of these mice at age 3 months (2 months on HFD) (B). Each bar
represents mean 6 SEM (n = 12–16/genotype).
(C) Ratio of fat mass to lean mass.
(D) Locomotor activity recorded by infrared sensors in these mice at 3 months of age in LD (mean 6 SEM, n = 7–10/genotype).
(E) Daily food intake during one 24 hr LD cycle (mean 6 SEM, n = 7–10/genotype).
*p < 0.05 and **p < 0.01 compared with WT mice (one-way ANOVA with LSD). See also Figure S3 and Table S1.
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376by the infrared sensor method that measures total activity
more accurately than wheel running [30]. Figure S3 depicts
this phenomenon as a comparison of rhythmic B1ko/B2Tg-1
mice with arhythmic B1ko/B2Tg-2 mice. When these two
groups of mice of the same genotype were separated on the
basis of their rhythmicity profiles as assessed by periodogram
analyses (Figure S3), we found that the arhythmic B1ko/
B2Tg-2 mice exhibited a significantly higher fat mass (p =
0.03) and lower total activity levels (p = 0.04, Table S1).
To confirm the conclusion that clock-disrupted mice are
obesity prone [22, 24], we tested another way to disrupt the
circadian system in WT animals. In particular, WT mice can
be rendered arhythmic (or their rhythms are severely disrup-
ted) by transferring them to constant light (LL), whereas they
remain strongly rhythmic in LD or constant darkness (DD) (Fig-
ure 5D). Arhythmia induced by light exposure also strongly
suppresses the expression of Bmal1 expression [46]. There-
fore, we compared LL as another way to effect rhythmicity
andmetabolism throughBmal1 expression. As further support
for the association of high body fat with the absence of rhyth-
micity, WT mice fed HFD were compared in LD 12:12 or LL
conditions. The body fat is significantly higher in arhythmic
WT mice in LL after feeding with HFD for 3 months as
compared with mice in LD (Figure 5A), whereas the lean
mass is not significantly altered in mice maintained in LL for
3 months (Figure 5B), resulting in a significant increase of fat
mass to lean mass ratio in WTmice exposed to LL (Figure 5C).
While the amount of total locomotor activity appears to be
lower for mice in LL as compared with LD, this difference is
not significant (Figure 5E), and these WT mice in LL accumu-
lated more body fat (Figure 5A) in spite of a trend toward
decreased food intake (Figure 5F). Consequently, LL leads to
disrupted rhythmicity and possibly to decreased locomotor
activity, which results in fat accumulation. This phenomenonis not restricted to mice; our results confirm observations of
a diabetes-prone rat strain that developedmetabolic dysregu-
lation after exposure to constant light for 10 weeks [47].
High-Fat-Diet Feeding Affects Subsequent Clock
Properties of Tissues In Vitro
Therefore, lack of rhythmicity is correlated with metabolic
dysfunction (Figures 1, 2, 3, 4, and 5) [2, 6], and the expression
of BMAL2 can rescue metabolic phenotypes associated with
the knockout of Bmal1 in intact mice. Feeding HFD to mice
leads to changes in the period of the (1) locomotor activity
rhythm and (2) cycling of central circadian clock genes in vivo
[23]. Do isolated tissues that can express circadian rhythms
in vitro also show correlations between expression patterns
and ‘‘after effects’’ of feeding HFD to the animals from
which the tissues are collected? The clockwork in the supra-
chiasmatic nuclei (SCN) of the hypothalamus is the ‘‘master’’
pacemaker that entrains to environmental cycles and coordi-
nates rhythms throughout the body [38, 48]. Outside of
the SCN, circadian molecular machinery exists and oscillates
in peripheral tissues—nearly every mammalian tissue ex-
presses circadian rhythms of clock gene expression in vivo
as measured by RNA microarrays and also when lumines-
cence reporters of gene activity are recorded from explanted
tissues in vitro [10, 14, 49]. Therefore, mammalian organisms
are a ‘‘clockshop’’ of circadian oscillators distributed through-
out the body [12].
In our previous study, we reported that isolated SCN, lung,
and liver slices from chow-fed animals exhibit circadian
rhythms of luminescence in vitro from WT and B2Tg animals,
but not from B1ko or B1ko/B2Tg mice [30]. However, damped
oscillations in liver could be elicited by treatment with gluco-
corticoids [30] (see Figure S4). That study, however, did not
test adipose tissue, nor did it test tissues from HFD-fed
Figure 5. Body Composition, Food Consumption, and Locomotor Activity in High-Fat-Diet-Fed Wild-Type Male Mice under Light/Dark or Constant Light
Conditions
Micewere fed regular chowuntil theywere 1month old, then transferred to HFD at 1month under either regular LD 12:12 (lights on 6:00 a.m.–6:00 p.m.) or LL.
(A and B) Fat mass (A) and lean mass (B) of 3- and 4-month-old WT male mice. Mice were fed with high-fat diet under either LD 12:12 (blue) or LL (red).
(C) Ratio of fat mass to lean mass. Each bar represents mean 6 SEM.
(D) Representative locomotor activity patterns recorded by infrared sensors. Blue shading denotes illumination, while white denotes darkness (left panel is
LD 12:12/ DD/ LD 12:12, right panel is LL).
(E) Activity levels are expressed as mean counts/min 6 SEM.
(F) Daily food intake is expressed as mean grams intake per 24 hr LD cycle 6 SEM.
n = 5–7 per treatment, **p < 0.01 and ***p < 0.001 compared with mice in LD (two-tail unpaired t test).
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377mice. Figure 6 shows that the PmPer2::mPER2-Luc reporter in
white adipose tissue (WAT) from the B1ko mouse does not
exhibit rhythmicity. Moreover, this was not rescued by Bmal2
expression in the B1ko/B2Tg mouse regardless of whether
the mouse was fed chow (Figure 6A) or a HFD (Figure 6B) prior
to sacrifice for the real-time luminescence assay. Therefore,
even though expression of Bmal2 is able to rescue metabolic
phenotypes of intact B1komice (Figures 2, 3, and 4), it appears
to be less effective in rescuing B1ko phenotypes in isolated
tissues of WAT (Figures 6A and 6B) or SCN, lung, or liver
[30]. An interesting observation, however, was an effect of
HFD on the period of the Per2 rhythm in WAT for wild-type
mice; the period in vitro was significantly longer in adipose
tissue from WT mice that had been fed HFD as compared
with chow (Figure 6C). This effect was not observed in B2Tg
mice, suggesting that constitutive expression of Bmal2 might
compensate for the HFD effect on period in WAT (Figure 6C).
Nonetheless, damped in vitro oscillations can be stimulated
by forskolin or glucocorticoid treatment of lung and liver of
B1ko/B2Tg mice (Figure S4) [30].
The SCN of the hypothalamus are the central neural pace-
maker of mammalian circadian clocks [50]. As we previously
reported [30], luminescence activity from SCN slices of B1ko
and B1ko/B2Tg mice was not rhythmic in vitro, and treatment
with forskolin to synchronize the cells in those tissue slices did
not reinitiate rhythmicity from tissues of those genotypes (Fig-
ure 6D). In addition, although we found that feeding HFD to
mice significantly lengthens the subsequent period of the
Per2 rhythm from WAT cultures in vitro (Figure 6C), we didnot observe an effect of prior HFD feeding on the period
of Per2 rhythms from SCN slices in vitro (Figures 6D–6F).
However, HFD feeding does enhance the amplitude of the
Per2 rhythm inWT SCN slices (Figures 6G and 6H). This obser-
vation suggests that a diet-induced change in fatty acid
metabolism of HFD-fed mice can alter clock properties, and
this alteration persists in tissues isolated from those mice
and subsequently assayed in vitro; the effect appears to be
true for both SCN pacemaker neurons (amplitude but not
period) and peripheral tissues such as WAT (period).
Discussion
Developed countries are facing an epidemic of interrelated
metabolic diseases collectively referred to as the metabolic
syndrome, the hallmarks of which include obesity, hyperlipid-
emia, hyperglycemia, insulin resistance, and hepatic steatosis
[51]. These symptoms are all independent risk factors of type 2
diabetes. By virtue of its pervasive control over metabolic
pathways, the circadian system might be a tractable target
for decreasing the prevalence of metabolic diseases, espe-
cially since the circadian system serves as the interface
between internal rhythms and the cycles of the external world
(light/dark, food availability, etc.). Indeed, studies in both mice
and humans indicate that relatively noninvasive manipulations
of the circadian patterns of activity and feeding can have
significant effects on body weight and metabolism [3, 9,
22, 52]. The results reported here conclusively demonstrate
the timing of insulin action is key; this conclusion is highly
Figure 6. Per2 Expression Measured as Luminescence Emanating from Tissues of the PmPer2::mPER2-Luc Reporter Mouse
WAT and SCN explants were dissected and recorded with a LumiCycle apparatus in vitro.
(A and B) Representative raw data of luminescencemonitored in vitro fromWAT of PmPer2::mPER2-Luc knockin mice [49] fedwith either chow (A) or HFD (B).
Colors denote the following: blue, WT; red, B2Tg; green, B1ko; and purple, B1ko/B2Tg.
(C) Period of Per2::luc luminescence rhythms from WAT explant cultures as mean 6 SEM (chow, white, n = 6–8/genotype; HFD, black, n = 5–7/genotype).
(D) Representative data of luminescence monitored in vitro from SCN slices of mice harboring PmPer2::mPER2-Luc and fed with HFD. After 7–8 days in
culture, the SCN slices were given a 0.5 hr pulse of 10 mM forskolin at the times indicated by red arrows (in vitro cultures were maintained at 36.5C).
Blue, WT; red, B2Tg; green, B1ko; purple, B1koB2Tg.
(E) Period of SCN cultures from HFD-fed mice. Each bar represents mean 6 SEM, n = 5–7/genotype.
(F) Period of SCN cultures from WT mice fed with chow or HFD. Each bar represents mean 6 SEM (chow, n = 8; HFD, n = 7).
(G) Amplitude of SCN cultures in arbitrary units (AU) from chow (open rectangle, n = 6–8/genotype) or HFD-fed mice (solid rectangle, n = 5–7).
(H) Detrended bioluminescence rhythms from cultured SCN slices of WT mice harboring PmPer2::mPER2-Luc and fed with chow or HFD. Each trace repre-
sents mean 6 SEM (chow, n = 8; HFD, n = 7).
*p < 0.05; **p < 0.01 compared with chow fed mice or as indicated (two-tailed unpaired t test). See also Figure S4.
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glycemia, and could alter strategies for insulin therapy.
While the fundamental concept of homeostasis would
predict that insulin activity and glucose levels would be
constant over the 24 hr day, our data clearly show that mice
are relatively insulin resistant in the middle of their subjective
day (CT7), i.e., during the inactive portion of the daily cycle
for mice (Figures 1 and S1). Moreover, fasting glucose shows
a circadian rhythm with the highest levels occurring during
the insulin-resistant phase of inactivity. The ‘‘clockless’’
B1ko mice appear to be locked arhythmically into this
insulin-resistant phase, as they demonstrate nonrhythmic
insulin-resistance and enhanced fasting glucose levels.
When circadian rhythmicity is rescued in the B1ko mouse by
transgenic expression of the Bmal1 paralog, Bmal2 [30], the
metabolic phenotypes of insulin resistance, fasting glucoselevels, Akt signaling, and fat accumulation are concomitantly
rescued (Figures 2, 3, and 4). Another way to induce arhyth-
micity and suppress Bmal1 expression—exposure to LL—
also lowers total activity and stimulates fat accumulation
(Figure 5).
The influence of HFD on metabolism not only affects behav-
ioral rhythms in vitro [23], but it also alters molecular clock
properties in WAT and SCN by a mechanism that persists for
at least several days in these tissues when isolated and
assayed in vitro (Figure 6). Moreover, the rescue of metabolic
phenotypes by expression of the Bmal2 gene may be medi-
ated by the partial restoration of circadian rhythmicity in
peripheral tissues such as liver and lung. In particular, the
damped oscillation capability in the isolated tissues of the
B1ko/B2Tg mouse (Figures 6 and S4) [30] are likely to return
to full-blown rhythmicity in vivo by virtue of systemic signals
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of peripheral tissues [53]. This is shown in Figure S4A, where
cyclic cAMP signals elicited by forskolin restore robust
rhythmic gene expression to fibroblasts derived from the
B1ko/B2Tgmouse but not to fibroblasts from theB1komouse.
Because B1ko/B2Tg-1 mice express rhythmic locomotor
activity, they are likely to have rhythmic systemic signals so
that peripheral tissues are also rhythmic and metabolism is
rescued. On the other hand, B1ko mice do not express
rhythmic behavior, and therefore B1ko peripheral tissues
may not experience rhythmic systemic signals, resulting in
metabolic defects.
The data reported here are consistent with a model derived
from studies of epigenomic regulation of metabolic switching
in mice [26]. During the night (active/feeding phase for mice),
metabolic intermediates are largely channeled to lipid
synthesis and storage, and we find this phase to be character-
ized by enhanced insulin activity and lower fasting glucose
(Figure 1). Conversely, during the day (inactive/fasting phase
for mice), metabolism switches into a calorie-restricted,
glucose-producing mode that is characterized by a higher
fasting glucose and insulin resistance. Clockless B1ko mice
appear to be locked in a metabolic state that resembles the
day phase of WT mice. This metabolic day/night switching
may be accomplished in WT mice by circadian regulation of
the histone deacetylase HDAC3 [26].
Our results have important implications for studies of insulin
action in mice. In particular, we show that insulin action
as measured by hyperinsulinemic-euglycemic clamps, per-
formed in the absence of stress (i.e., mice are not handled or
restrained and do not have their tails cut) varies over the
time span of the 24 hr day, confirming and extending some
previous studies of the interaction between circadian systems
and metabolism in which stress of handling and blood
sampling might have been a factor [28, 29, 31, 54]. Our current
studies emphasize the need to apply precise control to the
timing of metabolic experiments and to consider timing in
the interpretation of results. Some of the variance of results
among published studies that have been ascribed to diet,
mutant background, etc. could be at least partially due to
differing times of day when the hyperinsulinemic-euglycemic
clamps were performed [54].
Because most previous hyperinsulinemic-euglycemic
clamp studies of mice have been done in the day phase, it is
possible that gene-dependent effects on insulin action and
glucose metabolism that occur during the night phase have
been missed. Therefore, the conclusions of this investigation
indicate that results obtained from hyperinsulinemic-eugly-
cemic clamps and other measurements of insulin action and
glucose tolerance need to be considered in the context of
the time of day/circadian phase to facilitate comparison to
other studies. It would be most comprehensive to test insulin
action and glucose tolerance at different times of day, e.g.,
mid-day and mid-night to improve the chance of capturing
clock-dependent effects on metabolism.
From the work of Claude Bernard in the 19th century, the
concept of homeostasis (Bernard’s milieu inte´rieur) as the
maintenance of a constant internal environment is deeply
ingrained in our thinking about how organisms work. The
question then arises why is such a fundamental component
of internal environment as glucoregulation rhythmic rather
than constant? It is likely to be an inevitable and unavoidable
consequence of evolving in an external environment that is
profoundly rhythmic over the course of the daily cycle.Consequently, an organism whose responses are merely
constant will be outcompeted by organisms that anticipate
the predictable changes in their external environment by rhyth-
mically preparing and altering their internal environment. To
optimally adapt to a rhythmic environment, organisms must
rhythmically regulate their behavior, physiology, and gene
expression [55]. These studies show that insulin action and
glucose metabolism are intertwined with an internal time-
keeping system that evolved to accommodate the environ-
mental rhythmicity.
Experimental Procedures
Complete experimental procedures are described in the Supplemental
Experimental Procedures.
Animal Care
Micewere housed on a 12:12 hr light/dark cycle unless otherwise stated and
fed chow (5001; Purina Mills, St. Louis, MO) containing 13.5% calories from
fat. For HFD (F3282; BioServ, Frenchtown, NJ) experiments, mice were fed
HFD containing 60% calories as fat, beginning at 1 month of age. All animal
experiments were approved by the Vanderbilt University Institutional Animal
Care and Use Committee and were conducted according to that commit-
tee’s guidelines.
Hyperinsulinemic-Euglycemic Clamp
Detailed clamp procedures have been previously reported [33, 34] except
for the entrainment and circadian procedures shown in Figure S1 that are
unique to this study.
Determination of Akt Phosphorylation by Immunoblotting
Samples of liver and of vastus muscle harvested from mice of the CT13
group at the end of the hyperinsulinemic-euglycemic clamp procedure
were processed for immunoblotting and probed for total Akt, phosphory-
lated Akt (S473 and T308), MYC-BMAL2, BMAL1, b-ACTIN, and GAPDH.
Locomotor Behavior, Body Weight and/or Fat Composition, and Food
Intake Assays
Mice were fed HFD beginning at 1 month of age. After 2 months on HFD,
some mice were singly housed in cages equipped with infrared sensors.
Locomotor activity and food intake of the mice was measured at 2 months
on HFD. Body fat composition was determined with an mq10 nuclear
magnetic resonance analyzer (Bruker Optics).
Tissue Culture and In Vitro Luminescence Recording
The mice for tissue culture were fed HFD for 3 to 4.5 months or chow. The
cultures of SCN and peripheral tissues were prepared as previously
described [30, 49].
Statistics
Data are expressed as means 6 SEM. Statistical analyses were performed
by two-tail unpaired t test and by one-way and two-way ANOVA as
indicated.
Supplemental Information
Supplemental Information includes four figures, one table, and Supple-
mental Experimental Procedures and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2013.01.048.
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